XML 59 R37.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

FDA Refund (Details) - USD ($) | 1 Months Ended | 12 Months Ended
--- | --- | ---
Aug. 29, 2018 | Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2017
Fda Refund |  |  |  |
Refunded Amount of product and establishment fees | $ 818,343 |  |  |
Other income |  |  | $ 818,343 |

X
- References No definition available. + Details
Name: | ctxr_FdaRefundDetailsAbstract
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ctxr_RefundedAmountOfProductAndEstablishmentFees
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_OtherOperatingIncome
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration